<code id='F34DF565F9'></code><style id='F34DF565F9'></style>
    • <acronym id='F34DF565F9'></acronym>
      <center id='F34DF565F9'><center id='F34DF565F9'><tfoot id='F34DF565F9'></tfoot></center><abbr id='F34DF565F9'><dir id='F34DF565F9'><tfoot id='F34DF565F9'></tfoot><noframes id='F34DF565F9'>

    • <optgroup id='F34DF565F9'><strike id='F34DF565F9'><sup id='F34DF565F9'></sup></strike><code id='F34DF565F9'></code></optgroup>
        1. <b id='F34DF565F9'><label id='F34DF565F9'><select id='F34DF565F9'><dt id='F34DF565F9'><span id='F34DF565F9'></span></dt></select></label></b><u id='F34DF565F9'></u>
          <i id='F34DF565F9'><strike id='F34DF565F9'><tt id='F34DF565F9'><pre id='F34DF565F9'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:717
          Portrait of R. Shawn Martin -- health coverage from STAT
          R. Shawn Martin, the CEO of the American Academy of Family Physicians Courtesy American Academy of Family Physicians

          In ten years, the United States could be short as many as 48,000 primary care doctors. The specialty is underpaid, to a point that doctors are lobbying Medicare to pay it extra. Even medical residents who chose the specialty are leaving primary care; some 45% of residents who planned to be generalists changed their mind during their residencies.

          But R. Shawn Martin, the CEO of the American Academy of Family Physicians, the specialty trade group, isn’t worried.

          advertisement

          “I’ve been around this and at this a long time and family medicine and primary care’s obituary has been written many times in my 25-plus years of doing this work,” he said with a laugh. “This isn’t the first time that primary care has been dying or fading away.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          He's a Nobel laureate. Critics say he was misleading on Covid
          He's a Nobel laureate. Critics say he was misleading on Covid

          Photoillustration:AlexHogan/STAT;Sourcephoto:AFPviaGettyOnedaylastAugust,astheystruggledtofigureoutw

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Ed Silverman on new gene therapies, biosimilars, coffee, and more

          STAT'sEdSilvermanonstageattheSTATBreakthroughSummitin2023.SarahGonzalezforSTATIn2023,STATlaunchedabr